Search

everythinglearnresearchcommunity

for

Search:↓

Middle-aged women with chronic telogen effluvium experience increased hair shedding but usually don't get significantly thinner hair.

Telogen effluvium is a common type of hair loss that can resolve on its own or become chronic, with treatment depending on early diagnosis.

Oral minoxidil effectively reduces hair shedding in women with CTE, with no major side effects.

Telogen Effluvium is a condition causing excessive hair loss due to stress, illness, drugs, or hormonal changes, and can be treated with specific products or naturally resolves after 3-4 years.

Some people experienced temporary hair loss after hair transplant surgery but recovered fully within 10 months.

Oxidative stress is likely important in causing telogen effluvium, and antioxidants might help treat it.

Telogen Effluvium is a common hair loss condition that can be short-term or long-lasting and is often caused by stress, illness, or nutritional issues.

COVID-19 infection may cause significant hair loss, but full hair recovery is likely without special treatment.

The type 3 IP3 receptor is important for controlling hair loss and growth.

Telogen Effluvium is a common hair loss condition, particularly in women, with no specific FDA-approved treatment, and recovery can take up to 18 months.

Acute telogen effluvium can be resolved by addressing causes, but chronic telogen effluvium is harder to treat.

A vitamin and mineral supplement significantly reduced hair shedding in Brazilian women with telogen effluvium.

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

COVID-19 and related stress may increase hair loss known as Telogen effluvium.

The refined wash test is a reliable way to measure daily hair loss and can tell the difference between different types of hair loss.

Both Unani treatments effectively reduced hair shedding in Telogen Effluvium.

Higher cannabis exposure may lead to increased hair loss.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

COVID-19 may cause a temporary hair loss condition called telogen effluvium in some patients after recovery.

Teloptosis is a key point in hair loss that could help in creating prevention-focused hair care strategies.

The document explains hair growth and shedding, factors affecting it, and methods to evaluate hair loss, emphasizing the importance of skin biopsy for diagnosis.

COVID-19 may cause hair loss due to infection stress or treatments.

All three shampoos reduced dandruff and hair loss, but ketoconazole and piroctone olamine also made hair thicker.

Healthy women tend to lose more hair in July and April, and the least in February.

Scalp pain is a common symptom in people with active hair loss from telogen effluvium.

Sandalore® improves hair growth and quality in people with hair loss.

Emotional stress can trigger intermittent hair loss in chronic telogen effluvium, which may not improve with treatment if stress continues.

The article suggests that the belief in common postpartum hair loss lacks sufficient evidence and may be overestimated.

Only about 20% of women have hair loss after childbirth severe enough to be considered clinically significant.